Share This
Create Your Own Business Intelligence Website
 
Input the stock code or the company name     Search  

<00175.HK> - Geely Automobile Holdings Limited

 
 
 Basic Datum
Company name Lot P/E P/B EPS DPS
GEELY AUTO 1000 28.65 2.1134 0.5878 0.21
Profile Information Data Financial Ratios Profit Loss Cash Flow Balance Earnings Dividend
 
 
 
 Company Rating
Date Broker Company name Rating Target
06-09 Daiwa  GEELY AUTO 買入18
06-09 Daiwa  GEELY AUTO 買入18
06-08 C.Suisse  GEELY AUTO 跑贏大市18
≫More
 
 Company performance - Published
Date Company name Turnover* Profit* % Dividend
≫More
 
 Comment
2022-05-25 吉利汽車旗下「新實力國民轎跑」繽瑞COOL正式上市,新車共推出風馳版、電掣版和雷霆版共計3款車型,官方指導價為9.48萬-10.98萬元。
 
2022-06-22 依據乘聯會的銷量統計數據,2022年前五個月,吉利汽車累計零售銷量為422471台,比亞迪累計零售銷量為505901台。吉利汽車的銷量大約是比亞迪的80%。
 
 
 Top Gain / Loss Show All Charts 
 
 Value
Name Updated Value Change Change %
HSI 06-24 16:06 21719.1  445.19  2.09%
GEELY AUTO 06-24 16:08 17.94  17.94  ∞%
≫More
 
 Expert Commentary
2022-06-22 截至早上11時止,1小時內《彭博》用戶關注度上升最多港股,依次為中電控股(00002)、京東健康(06618)、金沙中國(01928)、吉利汽車(00175)、小米集團(01810)。 噚日醫療平台股升得唔錯,阿里健康(00241)更係升幅最大藍籌,但今日打回原形,睇返消息面,藥監局計劃禁止第三方平台直接參與藥品網售,雖然之前已講過只係徵求意見稿,而徵求意見已經截止,但市場似乎都係對呢類監管消息較敏感,醫療平台股今朝被震散。 獨立股評人譚智樂指,3隻醫療平台股股價走勢大同小異,因投資者都知道有監管因素,但隨著近期平台股有放寬跡象、手遊版號獲批發、電商平台營運數據有改善等,令市場憧憬所有監管因素有機會逐步消退,但問題在於當股價受惠於呢些利好因素時,發現原來只係市場「一廂情願」,市場睇得太好時,獲利回套沽壓可以好大,所以醫療平台股短線唔可以盲目樂觀,或認定監管一定會放寬。 Arnold補充,投資者可以將京東健康10天線作為「落車位」,再跌穿就要考慮走人。
2022-06-08 汽車股過去1個月幾乎全線跑贏大市,其中吉利汽車(00175)累升約30%,表現係一眾車股之中慨中游分子,同期表現最好反而係傳統車股長城汽車(02333),反映資金買貨時,唔係單睇一隻車股慨新能源車業務含量,係呢個前提下,邊隻車股最值博? 華盛証券分析師聶振邦指,睇返現階段慨資金流,主力係比亞迪股份(01211)及「3大造車新勢力」,理想汽車(02015)、小鵬汽車(09868)及蔚來(09866),佢又認為,不論吉利定長汽,依家慨聲勢都唔追唔上呢4隻股份,如果做中長線部署,比亞迪仍然係首選,若做短期部署,如博追落後,就可以考慮大市值慨蔚來,價格吸引就揀市帳率(PB)最平慨小鵬。
 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2022Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.